chr2-166281810-T-TA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001365536.1(SCN9A):c.1975-3dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0796 in 1,386,398 control chromosomes in the GnomAD database, including 1,634 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.069 ( 411 hom., cov: 31)
Exomes 𝑓: 0.081 ( 1223 hom. )
Consequence
SCN9A
NM_001365536.1 splice_region, intron
NM_001365536.1 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.261
Publications
4 publications found
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 2-166281810-T-TA is Benign according to our data. Variant chr2-166281810-T-TA is described in ClinVar as Benign. ClinVar VariationId is 167661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0743 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN9A | NM_001365536.1 | c.1975-3dupT | splice_region_variant, intron_variant | Intron 12 of 26 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN9A | ENST00000642356.2 | c.1975-3_1975-2insT | splice_region_variant, intron_variant | Intron 12 of 26 | NM_001365536.1 | ENSP00000495601.1 | ||||
| SCN9A | ENST00000303354.11 | c.1975-3_1975-2insT | splice_region_variant, intron_variant | Intron 12 of 26 | 5 | ENSP00000304748.7 | ||||
| SCN9A | ENST00000409672.5 | c.1942-3_1942-2insT | splice_region_variant, intron_variant | Intron 12 of 26 | 5 | ENSP00000386306.1 | ||||
| SCN9A | ENST00000645907.1 | c.1942-3_1942-2insT | splice_region_variant, intron_variant | Intron 12 of 26 | ENSP00000495983.1 | |||||
| SCN9A | ENST00000454569.6 | c.1942-3_1942-2insT | splice_region_variant, intron_variant | Intron 12 of 14 | 1 | ENSP00000413212.2 |
Frequencies
GnomAD3 genomes AF: 0.0690 AC: 10299AN: 149218Hom.: 411 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
10299
AN:
149218
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0930 AC: 13856AN: 148910 AF XY: 0.0953 show subpopulations
GnomAD2 exomes
AF:
AC:
13856
AN:
148910
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0809 AC: 100070AN: 1237090Hom.: 1223 Cov.: 29 AF XY: 0.0813 AC XY: 49907AN XY: 613726 show subpopulations
GnomAD4 exome
AF:
AC:
100070
AN:
1237090
Hom.:
Cov.:
29
AF XY:
AC XY:
49907
AN XY:
613726
show subpopulations
African (AFR)
AF:
AC:
1978
AN:
27218
American (AMR)
AF:
AC:
1710
AN:
33328
Ashkenazi Jewish (ASJ)
AF:
AC:
2656
AN:
21098
East Asian (EAS)
AF:
AC:
1631
AN:
32106
South Asian (SAS)
AF:
AC:
4417
AN:
68710
European-Finnish (FIN)
AF:
AC:
3364
AN:
44476
Middle Eastern (MID)
AF:
AC:
602
AN:
5008
European-Non Finnish (NFE)
AF:
AC:
79476
AN:
954910
Other (OTH)
AF:
AC:
4236
AN:
50236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
4189
8378
12568
16757
20946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3006
6012
9018
12024
15030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0690 AC: 10308AN: 149308Hom.: 411 Cov.: 31 AF XY: 0.0681 AC XY: 4960AN XY: 72860 show subpopulations
GnomAD4 genome
AF:
AC:
10308
AN:
149308
Hom.:
Cov.:
31
AF XY:
AC XY:
4960
AN XY:
72860
show subpopulations
African (AFR)
AF:
AC:
2397
AN:
40824
American (AMR)
AF:
AC:
1024
AN:
14934
Ashkenazi Jewish (ASJ)
AF:
AC:
396
AN:
3432
East Asian (EAS)
AF:
AC:
113
AN:
5124
South Asian (SAS)
AF:
AC:
217
AN:
4698
European-Finnish (FIN)
AF:
AC:
723
AN:
9924
Middle Eastern (MID)
AF:
AC:
42
AN:
290
European-Non Finnish (NFE)
AF:
AC:
5104
AN:
67094
Other (OTH)
AF:
AC:
166
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
455
910
1366
1821
2276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
Mar 12, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Inherited Erythromelalgia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Primary erythromelalgia;C0751122:Severe myoclonic epilepsy in infancy;C2751778:Generalized epilepsy with febrile seizures plus, type 7 Benign:1
Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:reference population
Generalized epilepsy with febrile seizures plus Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Congenital Indifference to Pain Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Small fiber neuropathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Paroxysmal extreme pain disorder Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Febrile seizures, familial Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Severe myoclonic epilepsy in infancy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.